<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Baek AE</submitter><funding>NIDDK NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>864</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5636879</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(1)</volume><pubmed_abstract>Obesity and elevated circulating cholesterol are risk factors for breast cancer recurrence, while the use of statins, cholesterol biosynthesis inhibitors widely used for treating hypercholesterolemia, is associated with improved disease-free survival. Here, we show that cholesterol mediates the metastatic effects of a high-fat diet via its oxysterol metabolite, 27-hydroxycholesterol. Ablation or inhibition of CYP27A1, the enzyme responsible for the rate-limiting step in 27-hydroxycholesterol biosynthesis, significantly reduces metastasis in relevant animal models of cancer. The robust effects of 27-hydroxycholesterol on metastasis requires myeloid immune cell function, and it was found that this oxysterol increases the number of polymorphonuclear-neutrophils and γδ-T cells at distal metast</pubmed_abstract><journal>Nature communications</journal><pubmed_title>The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells.</pubmed_title><pmcid>PMC5636879</pmcid><funding_grant_id>R01 DK095842</funding_grant_id><funding_grant_id>R01 DK048807</funding_grant_id><funding_grant_id>R00 CA172357</funding_grant_id><funding_grant_id>R01 DK062777</funding_grant_id><pubmed_authors>Kwon S</pubmed_authors><pubmed_authors>Sullivan PM</pubmed_authors><pubmed_authors>McDowell HB</pubmed_authors><pubmed_authors>Thompson JW</pubmed_authors><pubmed_authors>Gunn MD</pubmed_authors><pubmed_authors>Nelson ER</pubmed_authors><pubmed_authors>McDonnell DP</pubmed_authors><pubmed_authors>He S</pubmed_authors><pubmed_authors>Pillai RV</pubmed_authors><pubmed_authors>Dubois LG</pubmed_authors><pubmed_authors>Yu YA</pubmed_authors><pubmed_authors>Chang CY</pubmed_authors><pubmed_authors>Kemper JK</pubmed_authors><pubmed_authors>Wardell SE</pubmed_authors><pubmed_authors>Baek AE</pubmed_authors></additional><is_claimable>false</is_claimable><name>The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells.</name><description>Obesity and elevated circulating cholesterol are risk factors for breast cancer recurrence, while the use of statins, cholesterol biosynthesis inhibitors widely used for treating hypercholesterolemia, is associated with improved disease-free survival. Here, we show that cholesterol mediates the metastatic effects of a high-fat diet via its oxysterol metabolite, 27-hydroxycholesterol. Ablation or inhibition of CYP27A1, the enzyme responsible for the rate-limiting step in 27-hydroxycholesterol biosynthesis, significantly reduces metastasis in relevant animal models of cancer. The robust effects of 27-hydroxycholesterol on metastasis requires myeloid immune cell function, and it was found that this oxysterol increases the number of polymorphonuclear-neutrophils and γδ-T cells at distal metast</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Oct</publication><modification>2026-05-06T00:03:00.154Z</modification><creation>2019-03-27T02:58:42Z</creation></dates><accession>S-EPMC5636879</accession><cross_references><pubmed>29021522</pubmed><doi>10.1038/s41467-017-00910-z</doi></cross_references></HashMap>